American Cancer Society recommends routine prostate cancer screening for middle-aged men
The American Cancer Society updated its guidelines to advise regular PSA testing for men at average risk, while discouraging screening for those over 80 or with limited life expectancy.
The American Cancer Society announced Thursday that men at average risk of prostate cancer should undergo regular screening with a prostate-specific antigen (PSA) blood test. The recommendation marks a shift from the 2010 guidance, which suggested men discuss the test with their doctors rather than pursue routine screening.
The society said recent research has clarified the benefits of PSA testing and identified ways to limit potential harms, such as confirming elevated results with repeat tests and using MRI scans to determine the need for biopsies.
Screening is advised to begin in middle age, with men aged 70 advised to consult their physicians about continuing the tests. The guidelines advise against routine PSA screening for men 80 and older and for anyone whose life expectancy is less than ten years due to other health conditions.
Prostate cancer remains one of the most common cancers among men in the United States. The society estimates that more than 333,000 men will be diagnosed with the disease in 2026, and about 36,000 will die from it.